Alzheimer's Disease/Cognition News

Higher consumption of red meat, including processed red meat, was associated with a higher risk for cognitive decline and dementia, according to research published in Neurology.

The FDA has accepted Eisai and Biogen’s biologics license application for a monthly infusion of IV Leqembi to treat individuals with mild cognitive impairment or mild dementia consistent with early stage Alzheimer’s disease.

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose symptoms included fall risk and cognitive issues, data from JAMA Neurology show.

Topline results from a phase 2b/3 clinical trial of blarcamesine for individuals with early-stage Alzheimer’s disease showed that earlier initiation of the oral therapeutic led to significant disease slowing over 3 years.

A novel statistical model may be a reliable method to predict the age of onset for both mild cognitive impairment and Alzheimer’s disease-related dementia, according to research published in JAMA Network Open.

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests should only be ordered if the results will directly impact care, like when determining treatment eligibility.

Placental growth factor, a blood-based protein, may be a reliable method to detect abnormalities in the brain that presage cognitive impairment indicative of Alzheimer’s disease, data show.

Music may help improve cognitive function among people undergoing chemotherapy, according to results of a preliminary study.

A tai ji quan-based training program increased physical activity levels in older adults with mild cognitive impairment and increased risk for dementia, results from a secondary analysis of a randomized study showed.